Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.13 +0.03 (+0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atea Pharmaceuticals (AVIR) Return on Assets [ROA] (2020 - 2026)

Updated

Atea Pharmaceuticals' Return on Assets [ROA] came in at -66.20% for Q2 2026, down 33.46 percentage points from -32.74% a year earlier and down 7.98 percentage points from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Atea Pharmaceuticals' Return on Assets [ROA] was -40.61%, down 8.83 percentage points from FY2024.

  • Return on Assets [ROA] has declined in each of the last four years, with a five-year change of -38.14 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -31.78% in FY2024 (-10.23 pp), -21.55% in FY2023 (-5.45 pp), -16.10% in FY2022 (-30.91 pp) and 14.81% in FY2021 (+17.28 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Assets [ROA] in data going back to Q4 2020.
  • Year-over-year, Return on Assets [ROA] has declined for four consecutive quarters, with an average year-over-year change of -13.39 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2021 (a gain of 17.24 percentage points), and the weakest in Q2 2026 (a drop of 33.46 percentage points).
  • Business Quant data shows AVIR's Return on Assets [ROA] at -58.22% (Q1 2026), -48.12% (Q4 2025) and -40.03% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Atea Pharmaceuticals 411.45 Mn 411.45 Mn - -66.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -66.20%
Mar 31, 2026 -58.22%
Dec 31, 2025 -48.12%
Sep 30, 2025 -40.03%
Jun 30, 2025 -32.74%
Mar 31, 2025 -30.84%
Dec 31, 2024 -35.24%
Sep 30, 2024 -34.75%
Jun 30, 2024 -33.10%
Mar 31, 2024 -28.51%
Dec 31, 2023 -22.60%
Sep 30, 2023 -21.27%
Jun 30, 2023 -16.79%
Mar 31, 2023 -16.75%
Dec 31, 2022 -17.13%
Sep 30, 2022 5.16%
Jun 30, 2022 2.20%
Mar 31, 2022 6.50%
Dec 31, 2021 15.00%
Sep 30, 2021 2.88%
API Access

Atea Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEY